Cancer Incidence and Mortality for All Sites of Cancer, Richmond County (Staten Island), 2015-2019

Source: New York State Cancer Registry

Site of Cancer Incidence Mortality
Males and Females Males Females Males and Females Males Females
Average Annual Cases Rate per 100,000 Population 95% CI Average Annual Cases Rate per 100,000 Males 95% CI Average Annual Cases Rate per 100,000 Females 95% CI Average Annual Deaths Rate per 100,000 Population 95% CI Average Annual Deaths Rate per 100,000 Males 95% CI Average Annual Deaths Rate per 100,000 Females 95% CI
All Invasive Malignant Tumors 3061.4 528.9 520.3-537.6 1491.6 566.3 553.1-579.7 1569.8 506.1 494.6-517.8 854.6 145.5 141.1-150.1 420.8 168.3 161.0-175.9 433.8 129.9 124.3-135.6
Oral cavity and pharynx
All Oral cavity and pharynx 59.8 10.0 8.8-11.2 41.2 14.9 12.9-17.2 18.6 5.7 4.5-7.0 12.4 2.0 1.5-2.5 9.2 3.3 2.4-4.4 3.2 0.9 0.5-1.5
Lip 1.2 0.2 0.1-0.5 0.8 0.3 0.1-0.8 0.4 0.1 0.0-0.5 0.2 0.0 0.0-0.2 0.0 0.0 0.0-0.3 0.2 0.1 0.0-0.4
Tongue 17.8 2.9 2.3-3.6 12.8 4.5 3.5-5.9 5.0 1.4 0.9-2.2 2.2 0.3 0.2-0.6 1.4 0.5 0.2-1.1 0.8 0.2 0.1-0.6
Salivary gland 7.8 1.4 1.0-2.0 4.2 1.7 1.0-2.6 3.6 1.2 0.7-2.0 1.6 0.3 0.1-0.5 1.4 0.6 0.2-1.2 0.2 0.1 0.0-0.4
Floor of mouth 1.2 0.2 0.1-0.4 1.0 0.3 0.1-0.8 0.2 0.0 0.0-0.4 0.0 0.0 0.0-0.2 0.0 0.0 0.0-0.3 0.0 0.0 0.0-0.3
Gum & other mouth 11.2 1.9 1.4-2.5 6.0 2.3 1.5-3.3 5.2 1.5 1.0-2.3 1.8 0.3 0.1-0.6 1.2 0.5 0.2-1.0 0.6 0.2 0.0-0.5
Nasopharynx 3.0 0.5 0.3-0.8 2.2 0.8 0.4-1.5 0.8 0.2 0.1-0.6 2.8 0.5 0.2-0.8 1.8 0.7 0.3-1.3 1.0 0.3 0.1-0.7
Tonsil 10.8 1.8 1.3-2.4 8.6 3.1 2.2-4.2 2.2 0.7 0.3-1.3 0.6 0.1 0.0-0.3 0.6 0.2 0.0-0.6 0.0 0.0 0.0-0.3
Oropharynx 3.6 0.6 0.3-0.9 2.6 0.9 0.5-1.6 1.0 0.3 0.1-0.8 0.8 0.1 0.0-0.3 0.4 0.1 0.0-0.5 0.4 0.1 0.0-0.5
Hypopharynx 2.2 0.4 0.2-0.7 2.0 0.7 0.3-1.3 0.2 0.1 0.0-0.4 0.4 0.1 0.0-0.2 0.4 0.1 0.0-0.5 0.0 0.0 0.0-0.3
Other buccal cavity and pharynx 1.0 0.1 0.0-0.4 1.0 0.3 0.1-0.8 0.0 0.0 0.0-0.3 2.0 0.3 0.2-0.6 2.0 0.7 0.3-1.4 0.0 0.0 0.0-0.3
Digestive system
All Digestive system 522.4 88.9 85.5-92.5 290.2 109.7 103.9-115.6 232.2 71.8 67.6-76.1 246.0 41.3 39.0-43.7 132.8 50.7 46.8-54.9 113.2 33.7 30.9-36.6
Esophagus 28.2 4.6 3.9-5.4 22.0 7.9 6.5-9.6 6.2 1.9 1.3-2.8 18.6 3.1 2.5-3.8 13.8 5.0 3.8-6.3 4.8 1.5 0.9-2.3
Stomach 50.2 8.6 7.6-9.8 30.4 11.9 10.0-14.0 19.8 6.1 4.9-7.5 21.8 3.7 3.1-4.5 11.2 4.5 3.3-5.8 10.6 3.2 2.4-4.3
Small intestine 14.8 2.5 2.0-3.2 8.0 2.9 2.1-4.1 6.8 2.2 1.5-3.2 2.2 0.4 0.2-0.7 1.2 0.5 0.2-1.0 1.0 0.3 0.1-0.7
Colorectal 231.4 40.1 37.8-42.6 120.2 46.7 43.0-50.7 111.2 34.6 31.7-37.7 81.0 13.8 12.5-15.3 40.6 16.3 14.1-18.8 40.4 11.8 10.2-13.6
Colon excluding rectum 170.4 29.5 27.5-31.6 85.6 33.4 30.3-36.9 84.8 26.2 23.7-28.9 67.0 11.5 10.3-12.8 32.4 13.1 11.1-15.4 34.6 10.2 8.7-11.9
Cecum 27.2 4.7 3.9-5.6 9.4 3.6 2.6-4.9 17.8 5.4 4.3-6.7                  
Appendix 7.6 1.4 1.0-2.0 4.0 1.6 1.0-2.5 3.6 1.2 0.7-2.0                  
Ascending colon 37.8 6.6 5.7-7.6 20.8 8.5 6.9-10.4 17.0 5.1 4.0-6.3                  
Hepatic flexure 6.2 1.1 0.7-1.6 3.2 1.2 0.7-2.0 3.0 1.0 0.6-1.7                  
Transverse colon 15.2 2.5 2.0-3.2 8.4 3.1 2.2-4.3 6.8 2.1 1.4-3.0                  
Splenic flexure 5.0 0.9 0.6-1.4 2.4 1.0 0.5-1.8 2.6 0.9 0.5-1.5                  
Descending colon 12.2 2.1 1.6-2.7 6.2 2.3 1.5-3.3 6.0 1.9 1.3-2.7                  
Sigmoid colon 47.0 8.1 7.1-9.3 26.2 10.1 8.4-12.0 20.8 6.6 5.3-8.0                  
Large intestine, NOS 12.2 2.1 1.6-2.7 5.0 1.9 1.2-2.9 7.2 2.1 1.5-3.0                  
Rectum & rectosigmoid 61.0 10.6 9.4-11.9 34.6 13.3 11.3-15.5 26.4 8.3 6.9-10.0 14.0 2.3 1.8-3.0 8.2 3.2 2.3-4.4 5.8 1.6 1.1-2.3
Rectosigmoid junction 17.4 3.0 2.4-3.8 8.0 3.1 2.2-4.2 9.4 3.0 2.2-4.0                  
Rectum 43.6 7.6 6.6-8.7 26.6 10.2 8.5-12.2 17.0 5.4 4.3-6.7                  
Anus, anal canal & anorectum 12.0 2.0 1.5-2.5 5.6 2.0 1.3-3.0 6.4 1.8 1.2-2.7 1.8 0.3 0.1-0.6 0.6 0.2 0.0-0.7 1.2 0.3 0.1-0.8
Liver and intrahepatic bile duct 65.6 10.6 9.5-11.9 46.8 16.5 14.4-18.9 18.8 5.7 4.6-7.1 40.6 6.7 5.8-7.7 27.6 10.0 8.3-11.9 13.0 3.9 3.0-5.0
Liver 52.4 8.5 7.5-9.6 40.0 14.1 12.2-16.3 12.4 3.8 2.9-5.0 31.2 5.1 4.3-6.0 23.2 8.3 6.8-10.1 8.0 2.4 1.7-3.3
Intrahepatic bile duct 13.2 2.2 1.7-2.8 6.8 2.4 1.7-3.4 6.4 1.9 1.3-2.7 9.4 1.6 1.2-2.1 4.4 1.7 1.0-2.6 5.0 1.5 0.9-2.2
Gallbladder 9.2 1.7 1.2-2.2 2.6 1.0 0.5-1.8 6.6 2.1 1.5-3.1 4.8 0.8 0.5-1.2 2.4 0.9 0.5-1.6 2.4 0.7 0.4-1.3
Other biliary 9.6 1.6 1.2-2.2 4.8 1.8 1.2-2.8 4.8 1.5 1.0-2.3 2.6 0.4 0.2-0.7 1.2 0.4 0.1-0.9 1.4 0.4 0.2-0.9
Pancreas 92.4 15.5 14.1-17.0 45.4 17.0 14.8-19.5 47.0 14.2 12.4-16.2 70.4 11.7 10.5-13.1 33.6 12.7 10.8-14.9 36.8 11.0 9.4-12.7
Retroperitoneum 5.0 0.9 0.6-1.4 3.0 1.1 0.6-1.9 2.0 0.7 0.3-1.4 0.0 0.0 0.0-0.2 0.0 0.0 0.0-0.3 0.0 0.0 0.0-0.3
Peritoneum, omentum & mesentery 1.8 0.3 0.1-0.6 0.2 0.1 0.0-0.4 1.6 0.5 0.2-1.1 1.0 0.2 0.1-0.4 0.0 0.0 0.0-0.3 1.0 0.3 0.1-0.7
Other digestive organs 2.2 0.4 0.2-0.7 1.2 0.5 0.2-1.1 1.0 0.3 0.1-0.7 1.2 0.2 0.1-0.5 0.6 0.3 0.1-0.8 0.6 0.2 0.0-0.6
Respiratory system
All Respiratory system 413.6 69.9 66.9-73.1 202.4 78.3 73.4-83.5 211.2 64.4 60.5-68.5 214.0 36.4 34.2-38.7 108.0 43.3 39.6-47.2 106.0 31.6 28.9-34.5
Nasal cavity, middle ear & sinuses 4.8 0.8 0.5-1.2 2.2 0.9 0.4-1.6 2.6 0.8 0.4-1.4 0.4 0.1 0.0-0.3 0.2 0.1 0.0-0.4 0.2 0.0 0.0-0.4
Larynx 20.0 3.3 2.7-4.1 16.2 6.2 4.9-7.7 3.8 1.2 0.7-1.9 4.8 0.8 0.5-1.2 3.0 1.1 0.6-1.9 1.8 0.5 0.2-1.1
Lung and bronchus 388.2 65.7 62.7-68.7 183.6 71.1 66.5-76.0 204.6 62.3 58.5-66.4 207.8 35.3 33.2-37.6 104.4 41.9 38.3-45.8 103.4 30.8 28.1-33.6
Pleura 0.0 0.0 0.0-0.2 0.0 0.0 0.0-0.3 0.0 0.0 0.0-0.3 0.4 0.1 0.0-0.3 0.4 0.2 0.0-0.7 0.0 0.0 0.0-0.3
Trachea, mediastinum, other respiratory 0.6 0.1 0.0-0.3 0.4 0.2 0.0-0.6 0.2 0.1 0.0-0.4 0.6 0.1 0.0-0.4 0.0 0.0 0.0-0.3 0.6 0.2 0.0-0.7
Soft tissue, bone, and skin
Bones & joints 7.4 1.5 1.0-2.0 3.8 1.6 1.0-2.6 3.6 1.3 0.8-2.2 2.6 0.5 0.3-0.9 1.6 0.8 0.3-1.5 1.0 0.3 0.1-0.8
Soft tissue (including heart) 18.0 3.4 2.7-4.2 9.4 3.8 2.8-5.1 8.6 3.0 2.2-4.1 7.6 1.3 0.9-1.8 3.2 1.2 0.7-2.0 4.4 1.5 0.9-2.2
Skin~ 99.2 17.5 16.0-19.2 55.8 22.0 19.4-24.9 43.4 14.2 12.3-16.3 12.6 2.2 1.7-2.8 7.4 3.2 2.3-4.5 5.2 1.5 1.0-2.3
Melanoma of the skin 85.8 15.0 13.6-16.6 48.6 19.0 16.6-21.6 37.2 12.2 10.4-14.1 8.4 1.5 1.1-2.0 4.6 2.1 1.3-3.2 3.8 1.1 0.7-1.8
Breast
Breast 427.2 75.2 71.9-78.5 3.8 1.5 0.9-2.3 423.4 138.1 132.1-144.4 59.4 10.0 8.9-11.2 0.8 0.3 0.1-0.9 58.6 17.2 15.3-19.4
Breast (in situ)* 135.6 24.7 22.8-26.7 0.4 0.2 0.0-0.7 135.2 46.3 42.8-50.1                  
Female genital system
All Female genital system             202.0 64.0 60.0-68.3             53.8 16.1 14.2-18.2
Cervix uteri             21.8 8.0 6.5-9.7             5.6 1.8 1.2-2.7
Corpus uterus and NOS             121.2 37.0 34.0-40.2             21.8 6.6 5.4-8.0
Ovary             42.6 13.8 12.0-15.9             23.0 6.7 5.5-8.1
Vagina             3.2 1.1 0.6-1.8             0.2 0.1 0.0-0.4
Vulva             7.6 2.3 1.6-3.2             2.2 0.6 0.3-1.2
Other female genital organs             5.6 1.9 1.2-2.7             1.0 0.3 0.1-0.8
Male genital system
All Male genital system       360.4 128.6 122.6-134.9             38.8 17.1 14.8-19.8      
Prostate       344.0 121.2 115.4-127.3             37.4 16.6 14.3-19.2      
Testis       13.6 6.3 4.9-8.0             0.4 0.2 0.0-0.6      
Penis       2.0 0.8 0.4-1.5             0.6 0.2 0.0-0.6      
Other male genital organs       0.8 0.3 0.1-0.8             0.4 0.2 0.0-0.7      
Urinary system
All Urinary system 287.2 48.8 46.2-51.4 207.0 79.5 74.5-84.6 80.2 24.6 22.2-27.2 51.6 8.8 7.8-10.0 37.6 15.5 13.3-17.9 14.0 4.2 3.2-5.3
Urinary bladder (including in situ) 152.4 25.8 24.0-27.7 115.2 45.2 41.4-49.1 37.2 11.1 9.5-12.9 28.8 5.0 4.2-5.9 20.8 9.0 7.3-11.0 8.0 2.3 1.7-3.2
Kidney and renal pelvis 127.2 21.7 20.0-23.5 86.6 32.3 29.3-35.6 40.6 12.7 11.0-14.7 21.2 3.6 2.9-4.4 15.8 6.1 4.8-7.7 5.4 1.6 1.1-2.4
Ureter 5.4 0.9 0.6-1.3 3.8 1.5 0.9-2.3 1.6 0.5 0.2-1.0 0.8 0.1 0.0-0.3 0.6 0.2 0.0-0.7 0.2 0.1 0.0-0.4
Other urinary organs 2.2 0.4 0.2-0.7 1.4 0.5 0.2-1.1 0.8 0.3 0.1-0.7 0.8 0.1 0.0-0.4 0.4 0.1 0.0-0.5 0.4 0.1 0.0-0.5
Eye & orbit
Eye & orbit 4.2 0.7 0.5-1.2 1.4 0.5 0.2-1.2 2.8 0.9 0.5-1.6 0.6 0.1 0.0-0.3 0.0 0.0 0.0-0.3 0.6 0.2 0.0-0.6
Brain and central nervous system
All Brain / other central nervous system (all behaviors) 121.0 21.8 20.0-23.6 48.4 19.1 16.7-21.8 72.6 23.8 21.3-26.5 22.8 3.9 3.2-4.7 12.0 4.5 3.4-5.8 10.8 3.3 2.5-4.4
Malignant brain / other central nervous system 37.0 6.8 5.8-7.9 18.8 7.4 6.0-9.2 18.2 6.2 4.9-7.6 21.2 3.6 2.9-4.4 11.4 4.2 3.2-5.6 9.8 3.1 2.2-4.1
Malignant brain 35.0 6.4 5.5-7.5 17.8 7.0 5.6-8.7 17.2 5.8 4.6-7.3                  
Malignant other central nervous system 2.0 0.4 0.2-0.7 1.0 0.4 0.1-0.9 1.0 0.3 0.1-0.8                  
Benign brain / other central nervous system* 84.0 15.0 13.5-16.5 29.6 11.7 9.8-13.8 54.4 17.6 15.5-19.9 1.6 0.3 0.1-0.6 0.6 0.2 0.0-0.7 1.0 0.3 0.1-0.7
Benign brain 6.2 1.3 0.9-1.8 4.0 1.7 1.0-2.6 2.2 0.9 0.5-1.7                  
Benign other central nervous system 77.8 13.7 12.3-15.2 25.6 10.0 8.3-12.0 52.2 16.7 14.7-18.9                  
Endocrine system
All Endocrine system 178.6 34.6 32.3-37.0 53.2 21.1 18.6-23.9 125.4 47.2 43.4-51.2 4.6 0.8 0.5-1.2 2.2 0.9 0.4-1.6 2.4 0.8 0.4-1.4
Thyroid 173.8 33.8 31.5-36.2 50.0 19.9 17.4-22.6 123.8 46.7 42.9-50.7 3.8 0.6 0.4-1.0 1.8 0.7 0.3-1.4 2.0 0.6 0.3-1.1
Other endocrine (including thymus) 4.8 0.8 0.5-1.2 3.2 1.2 0.7-2.0 1.6 0.5 0.2-1.1 0.8 0.2 0.0-0.4 0.4 0.2 0.0-0.7 0.4 0.2 0.0-0.6
Lymphomas
All Lymphomas 159.2 28.6 26.6-30.7 85.0 33.9 30.6-37.3 74.2 24.1 21.6-26.8 26.4 4.7 3.9-5.6 16.0 6.6 5.2-8.3 10.4 3.2 2.3-4.2
Hodgkin lymphoma 17.0 3.5 2.8-4.3 10.8 4.6 3.4-6.0 6.2 2.5 1.6-3.5 2.6 0.4 0.2-0.8 1.8 0.7 0.3-1.3 0.8 0.3 0.1-0.7
Non-Hodgkin lymphomas 142.2 25.1 23.2-27.1 74.2 29.3 26.3-32.5 68.0 21.6 19.3-24.2 23.8 4.3 3.5-5.1 14.2 5.9 4.6-7.6 9.6 2.9 2.1-3.9
Myeloma
All Myeloma 52.6 8.9 7.8-10.1 29.0 11.2 9.4-13.3 23.6 7.0 5.8-8.5 15.6 2.6 2.1-3.3 8.8 3.4 2.4-4.6 6.8 2.1 1.4-2.9
Leukemias
All Leukemias 103.6 18.5 16.9-20.3 62.8 24.7 22.0-27.7 40.8 13.6 11.8-15.7 35.2 6.3 5.4-7.4 17.2 7.5 5.9-9.3 18.0 5.6 4.5-7.0
Lymphocytic leukemias 52.0 9.3 8.1-10.5 31.6 12.3 10.4-14.5 20.4 6.9 5.5-8.4 7.8 1.4 1.0-1.9 4.0 1.7 1.0-2.6 3.8 1.2 0.7-1.9
Acute lymphocytic leukemia 8.0 1.8 1.3-2.5 3.6 1.7 1.0-2.6 4.4 2.0 1.2-3.0 1.8 0.3 0.2-0.7 0.4 0.2 0.0-0.6 1.4 0.5 0.2-1.1
Chronic lymphocytic leukemia 39.8 6.7 5.8-7.7 24.4 9.4 7.8-11.3 15.4 4.6 3.6-5.8 6.0 1.0 0.7-1.5 3.6 1.5 0.9-2.4 2.4 0.7 0.3-1.2
Other lymphocytic leukemias 4.2 0.7 0.4-1.1 3.6 1.3 0.7-2.0 0.6 0.2 0.0-0.7 0.0 0.0 0.0-0.2 0.0 0.0 0.0-0.3 0.0 0.0 0.0-0.3
Myeloid and monocytic leukemias 46.4 8.4 7.3-9.6 28.2 11.3 9.5-13.4 18.2 6.1 4.9-7.5 19.8 3.6 2.9-4.4 10.2 4.4 3.3-5.9 9.6 3.1 2.3-4.2
Acute myeloid leukemia 30.2 5.5 4.7-6.5 16.8 6.9 5.4-8.6 13.4 4.5 3.5-5.8 17.2 3.1 2.5-3.9 8.6 3.8 2.7-5.1 8.6 2.8 2.0-3.9
Acute monocytic leukemia 1.2 0.2 0.1-0.5 1.0 0.4 0.1-0.9 0.2 0.1 0.0-0.5 0.0 0.0 0.0-0.2 0.0 0.0 0.0-0.3 0.0 0.0 0.0-0.3
Chronic myeloid leukemia 13.8 2.4 1.9-3.1 9.6 3.7 2.7-4.9 4.2 1.4 0.8-2.1 2.0 0.4 0.2-0.7 1.2 0.5 0.2-1.2 0.8 0.2 0.1-0.7
Other myeloid/monocytic leukemias 1.2 0.2 0.1-0.5 0.8 0.4 0.1-0.9 0.4 0.1 0.0-0.5 0.6 0.1 0.0-0.3 0.4 0.2 0.0-0.6 0.2 0.0 0.0-0.4
Other leukemias 5.2 0.9 0.6-1.3 3.0 1.1 0.6-1.8 2.2 0.7 0.3-1.3 7.6 1.4 1.0-1.9 3.0 1.4 0.7-2.2 4.6 1.3 0.8-2.0
Other acute leukemias 1.2 0.2 0.1-0.5 0.8 0.3 0.1-0.8 0.4 0.1 0.0-0.5 2.6 0.4 0.2-0.8 0.8 0.4 0.1-0.9 1.8 0.5 0.2-0.9
Aleukemic, subacute, leukemia NOS 4.0 0.7 0.4-1.1 2.2 0.8 0.4-1.5 1.8 0.6 0.3-1.1 5.0 0.9 0.6-1.4 2.2 1.0 0.5-1.8 2.8 0.9 0.5-1.5
Mesothelioma
Mesothelioma 7.0 1.3 0.9-1.8 5.2 2.3 1.5-3.4 1.8 0.5 0.2-1.1                  
Kaposi sarcoma
Kaposi sarcoma 5.0 0.9 0.6-1.4 3.8 1.6 1.0-2.6 1.2 0.4 0.1-0.9                  
Myelodysplastic syndromes
Myelodysplastic syndromes 26.4 4.7 4.0-5.6 15.2 6.6 5.1-8.2 11.2 3.4 2.5-4.4                  
Chronic myeloproliferative disorders^
Chronic myeloproliferative disorders^ 38.6 7.2 6.2-8.3 18.0 7.3 5.8-9.0 20.6 7.0 5.7-8.6                  
Ill defined and unspecified sites
Ill defined and unspecified sites 52.0 9.1 8.0-10.3 25.2 9.7 8.0-11.6 26.8 8.5 7.1-10.1 52.2 9.2 8.1-10.4 25.8 10.2 8.5-12.2 26.4 8.2 6.8-9.7

Key

Symbol Meaning
~ Incidence of skin cancer excludes basal and squamous cell cancers.
* Breast in situ and Brain/other central nervous system tumors with benign or uncertain behaviors are not included in the total for all invasive malignant tumors.
^ Tumors with a histology of 9963 or 9964 are included under Aleukemic, Subacute, Leukemia NOS, instead of Chronic Myeloproliferative Disorder.

Notes

  • Incidence data are provisional, November 2021.
  • Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
  • Rates based on fewer than 4 cases or deaths per year are unstable and should be used with caution. NOS = Not otherwise specified.